Kraig Biocraft Laboratories (KBLB) Enterprise Value (2016 - 2022)
Kraig Biocraft Laboratories (KBLB) has disclosed Enterprise Value for 10 consecutive years, with -$4.3 million as the latest value for Q3 2022.
- Quarterly Enterprise Value fell 60.54% to -$4.3 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was -$4.3 million through Sep 2022, down 60.54% year-over-year, with the annual reading at -$2.4 million for FY2021, N/A changed from the prior year.
- Enterprise Value hit -$4.3 million in Q3 2022 for Kraig Biocraft Laboratories, up from -$4.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$13697.0 in Q4 2018 to a low of -$4.8 million in Q2 2022.
- Historically, Enterprise Value has averaged -$1.9 million across 4 years, with a median of -$927038.0 in 2021.
- Biggest five-year swings in Enterprise Value: soared 69.98% in 2018 and later crashed 1857.97% in 2019.
- Year by year, Enterprise Value stood at -$13697.0 in 2018, then crashed by 1967.23% to -$283148.0 in 2019, then crashed by 731.74% to -$2.4 million in 2021, then crashed by 83.62% to -$4.3 million in 2022.
- Business Quant data shows Enterprise Value for KBLB at -$4.3 million in Q3 2022, -$4.8 million in Q2 2022, and -$3.9 million in Q1 2022.